Said Dermime

7.6k total citations · 3 hit papers
101 papers, 5.6k citations indexed

About

Said Dermime is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Said Dermime has authored 101 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 41 papers in Oncology and 38 papers in Immunology. Recurrent topics in Said Dermime's work include Immunotherapy and Immune Responses (28 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Immune Cell Function and Interaction (17 papers). Said Dermime is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Immune Cell Function and Interaction (17 papers). Said Dermime collaborates with scholars based in Qatar, United States and Saudi Arabia. Said Dermime's co-authors include Shahab Uddin, Maysaloun Merhi, Hazem Ghebeh, Asma Tulbah, Taher Al‐Tweigeri, Naser Elkum, Varghese Inchakalody, Kirti S. Prabhu, Kodappully Sivaraman Siveen and Shilpa Kuttikrishnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Said Dermime

99 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic Factors

2006 504 citations Hazem Ghebeh, Cynthia Lehé et al. profile →
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

2023 373 citations Karama Makni‐Maalej, Maysaloun Merhi et al. profile →
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines

2022 261 citations Queenie Fernandes, Varghese Inchakalody et al. profile →

Peers

Countries citing papers authored by Said Dermime

Since Specialization

Citations

This map shows the geographic impact of Said Dermime's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Said Dermime with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Said Dermime more than expected).

Fields of papers citing papers by Said Dermime

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Said Dermime. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Said Dermime. The network helps show where Said Dermime may publish in the future.

Co-authorship network of co-authors of Said Dermime

This figure shows the co-authorship network connecting the top 25 collaborators of Said Dermime. A scholar is included among the top collaborators of Said Dermime based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Said Dermime. Said Dermime is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Internal Ribosome Entry Site in Circular RNAs 2025 ·Advances in experimental medicine and biology ·Queenie Fernandes, (unknown), S Mestiri, (unknown), Karama Makni‐Maalej, Shahab Uddin, Maysaloun Merhi, Said Dermime	0
2	The apoptotic and anti‐proliferative effects of Neosetophomone B in T‐cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition 2024 ·Cell Proliferation ·Shilpa Kuttikrishnan, Abdul W. Ansari, Muhammad Suleman, Fareed Ahmad, Kirti S. Prabhu, Tamam El‐Elimat, Feras Q. Alali, Ammira Al‐Shabeeb Akil, Ajaz A. Bhat, Maysaloun Merhi, Said Dermime, Martin Steinhoff, Shahab Uddin	2
3	Targeting HER2-positive breast cancer cells by a combination of dasatinib and BMS-202: Insight into the molecular pathways 2024 ·Cancer Cell International ·(unknown), Ishita Gupta, Farhan Cyprian, Semir Vranić, (unknown), Maysaloun Merhi, Said Dermime, Ala‐Eddin Al Moustafa	4
4	Chronic inflammation and cancer; the two sides of a coin 2023 ·Life Sciences ·Queenie Fernandes, Varghese Inchakalody, Takwa Bedhiafi, S Mestiri, Nassiba Taib, Shahab Uddin, Maysaloun Merhi, Said Dermime	55
5	Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy 2023 ·Journal of Translational Medicine ·Nassiba Taib, Maysaloun Merhi, Varghese Inchakalody, S Mestiri, (unknown), Karama Makni‐Maalej, Afsheen Raza, (unknown), Fouad Azizi, (unknown), Queenie Fernandes, (unknown), (unknown), Lobna Al-Zaidan, (unknown), Shahab Uddin, Cristina Maccalli, (unknown), Said Dermime	13
6	Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma 2022 ·Journal for ImmunoTherapy of Cancer ·Mona O. Mohsen, Daniel E. Speiser, Justine Michaux, HuiSong Pak, Brian J. Stevenson, Monique Vogel, Varghese Inchakalody, Simone de Brot, Said Dermime, George Coukos, Michal Bassani‐Sternberg, Martin F. Bachmann	24
7	Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity 2021 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Maysaloun Merhi, Varghese Inchakalody, Shahab Uddin, Darawan Rinchai, Davide Bedognetti, Said Dermime	24
8	Neutralization of MERS coronavirus through a scalable nanoparticle vaccine 2021 ·npj Vaccines ·Mona O. Mohsen, (unknown), Ina Baļķe, B Martina, (unknown), Varghese Inchakalody, (unknown), Gheyath K. Nasrallah, Said Dermime, Kaspars Tārs, Monique Vogel, Andris Zeltiņš, Martin F. Bachmann	11
9	Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling 2019 ·Frontiers in Oncology ·Sabah Akhtar, Iman W. Achkar, Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, Kirti S. Prabhu, Abdul Quaiyoom Khan, Eiman I. Ahmed, (unknown), Jayakumar Jerobin, Afsheen Raza, Maysaloun Merhi, (unknown), Ruba Y. Taha, Halima El Omri, Hatem Zayed, Said Dermime, Martin Steinhoff, Shahab Uddin	36
10	NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives 2018 ·Frontiers in Immunology ·Remy Thomas, (unknown), Jessica Roelands, Wouter Hendrickx, Said Dermime, Davide Bedognetti, Julie Decock	284
11	Greensporone C, a Freshwater Fungal Secondary Metabolite Induces Mitochondrial-Mediated Apoptotic Cell Death in Leukemic Cell Lines 2018 ·Frontiers in Pharmacology ·Kirti S. Prabhu, Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, Ahmad Iskandarani, Abdul Quaiyoom Khan, Maysaloun Merhi, Halima El Omri, Said Dermime, Tamam El‐Elimat, Nicholas H. Oberlies, Feras Q. Alali, Shahab Uddin	24
12	The immunoinhibitory B7-H1 molecule as a potential target in cancer 2014 ·Hematology/Oncology and Stem Cell Therapy ·Said Dermime, (unknown)	87
13	Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor 2014 ·Hematology/Oncology and Stem Cell Therapy ·Talal Al‐Harbi, (unknown), (unknown), Said Dermime	28
14	Identification of a novel peptide derived from the M-phase phosphoprotein 11 (MPP11) leukemic antigen recognized by human CD8+ cytotoxic T lymphocytes 2010 ·Hematology/Oncology and Stem Cell Therapy ·(unknown), Cynthia Lehé, Anne M. Dickinson, (unknown), Walid Rasheed, Naeem Chaudhri, Mahmoud Aljurf, Said Dermime	7
15	Breast Carcinoma–Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes 2008 ·Cancer Research ·(unknown), Hazem Ghebeh, Siti‐Faujiah Hendrayani, Asma Tulbah, (unknown), Taher Al‐Tweigeri, Dahish Ajarim, Ayodele Alaiya, Said Dermime, Abdelilah Aboussekhra	123
16	The Wilms' Tumor Antigen Is a Novel Target for Human CD4+ Regulatory T Cells: Implications for Immunotherapy 2008 ·Cancer Research ·Cynthia Lehé, Hazem Ghebeh, (unknown), (unknown), Khaled Al‐Hussein, (unknown), Naeem Chaudhri, Fahad Alsharif, (unknown), Abdelghani Tbakhi, Mahmoud Aljurf, Said Dermime	35
17	Use of adenoviruses encoding CD40L or IL‐2 against B cell lymphoma 2004 ·International Journal of Cancer ·(unknown), Tapan Bhattacharyya, Anne Armstrong, Cheng Qian, Robert E. Hawkins, Peter L. Stern, Said Dermime	16
18	Immunization with a Recombinant Adenovirus Encoding a Lymphoma Idiotype: Induction of Tumor-Protective Immunity and Identification of an Idiotype-Specific T Cell Epitope 2002 ·The Journal of Immunology ·Anne Armstrong, Said Dermime, (unknown), Tapan Bhattacharyya, (unknown), (unknown), Peter L. Stern, Robert E. Hawkins	42
19	Cancer vaccines and immunotherapy 2002 ·British Medical Bulletin ·Said Dermime, Anne Armstrong, Robert E. Hawkins, Peter L. Stern	51
20	Preferential usage of T cell receptor (TCR) V β by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease 1997 ·Bone Marrow Transplantation ·(unknown), (unknown), Said Dermime, Jeffrey J. Molldrem, (unknown), A. John Barrett	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact